Evidence map›Paper›PMID 19220914›Full record

ArticleRetrovirology2009

HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression.

Zachary Klase, Rafael Winograd, Jeremiah Davis, Lawrence Carpio, Richard Hildreth, Mohammad Heydarian, Sidney Fu, Timothy McCaffrey, Eti Meiri, Mila Ayash-Rashkovsky and 3 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 158 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Zachary KlaseThe Department of Microbiology, Immunology and Tropical Medicine program, The George Washington University School of Medicine, Washington, District of Columbia 20037, USA. bcmzak@gwumc.edu
Rafael Winograd
Jeremiah Davis
Lawrence Carpio
Richard Hildreth
Mohammad Heydarian
Sidney Fu
Timothy McCaffrey
Eti Meiri
Mila Ayash-Rashkovsky
Shlomit Gilad
Zwi Bentwich
Fatah Kashanchi
George Washington University · USRosetta Genomics (Israel) · IL

Funding

HIV1 INHIBITION USING TAT PEPTIDE DERIVATIVESR01AI043894 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KASHANCHI, FATAH · 1999 to 2015
$4.4M
Effect on cdk inhibitor in HIV-1 replicationR21AI065236 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2006 to 2007
$415k
NIAID NIH HHS AI043894NIAID NIH HHS AI065236NIAID NIH HHS R01 AI043894NIAID NIH HHS R21 AI065236
6 · The paper itself

Abstract

backgroundRNA interference is a gene regulatory mechanism that employs small RNA molecules such as microRNA. Previous work has shown that HIV-1 produces TAR viral microRNA. Here we describe the effects of the HIV-1 TAR derived microRNA on cellular gene expression.

resultsUsing a variation of standard techniques we have cloned and sequenced both the 5' and 3' arms of the TAR miRNA. We show that expression of the TAR microRNA protects infected cells from apoptosis and acts by down-regulating cellular genes involved in apoptosis. Specifically, the microRNA down-regulates ERCC1 and IER3, protecting the cell from apoptosis. Comparison to our cloned sequence reveals possible target sites for the TAR miRNA as well.

conclusionThe TAR microRNA is expressed in all stages of the viral life cycle, can be detected in latently infected cells, and represents a mechanism wherein the virus extends the life of the infected cell for the purpose of increasing viral replication.

Indexed as

Gene Expression RegulationApoptosisBase SequenceCaspase 3Cell LineDNA-Binding ProteinsEndonucleasesHeLa CellsHIV-1HIV InfectionsHIV Long Terminal RepeatHost-Pathogen InteractionsHumansMicroRNAsRibonuclease IIISequence AlignmentCaspase 3DNA-Binding ProteinsEndonucleasesERCC1 protein, humanMicroRNAsRibonuclease III

Identifiers

PMID19220914
PMCPMC2654423
OpenAlexW2041751293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.